DNA and RNA Profiling Using Simultaneous Sequencing (Simul-seq)
Demographics (1)
- sex - Gender of participant (phv00270115.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for esophageal adenocarcinoma (phv00270109.v1.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00270146.v1.p1)
Other (19)
- ANALYTE_TYPE - Analyte Type (phv00270118.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00270117.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00270107.v1.p1)
- HISTOLOGIC_STAGE - Histologic staging of tumor sample (phv00270123.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00270120.v1.p1)
- IS_TUMOR - Tumor status (phv00270119.v1.p1)
- PATHOLOGIC_STAGE - TNM pathologic staging (phv00270124.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00270121.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00270122.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00270116.v1.p1)
- SAMPLE_ID - Sample ID (phv00270111.v1.p1)
- SAMPLE_SOURCE - Source repository where samples originate (phv00270112.v1.p1)
- SAMPLE_USE - Sample Use (phv00270113.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00270126.v1.p1)
- SUBJECT_ID - Subject ID (phv00270106.v1.p1)
- SUBJECT_ID - Subject ID (phv00270110.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00270114.v1.p1)
- SUBJECT_SOURCE - Source repository where subjects originate (phv00270108.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00270125.v1.p1)